5810 Results for “ https://www.galaxus.ch/en/sector/showdiscussion/snap-hack-online-visit-kunghaccom-d2d1mo9k-226342”

What if the AI future being sold to markets rests on claims that cannot survive scrutiny? From superintelligence to mass job loss, the loudest promises around generative AI begin to look less like foresight than hype dressed up as inevitability.

There is no good case for major deregulation of the US financial sector, warns INET Board Chairman Adair Turner, and any backsliding by a Trump administration on banks’ capital requirements instituted globally after 2008 will be very dangerous

The objective of this proposal is to build distributional statistics of income and wealth consistent with national accounts aggregates for the United States.

Chaired by Nobel laureates Joseph Stiglitz and Michael Spence, INET has assembled a global team of leaders and scholars calling for new thinking & new rules for the world economy

Times have changed. Now we have David Brooks, of The New York Times, and economics blogger Noah Smith defending neoliberal globalization from the pincer movement of anti-trade populists from both the right and the left.

Sanctions on Russia are isomorphic to a strict policy of trade protection, industrial policy, and capital controls.

What we’re reading: A weekly scan of published items relevant to the Institute’s work

Painting economics as blind to inequality may be overstating matters, but for too long efforts to explain it have been self limiting. Now, new economic thinkers are willing to pose uncomfortable questions.

The most likely outcome of the second Trump administration is a recession and an exacerbation of inequalities, and a further degradation of the living standards of working and middle-class Americans.

The corrosive social and economic effects of what have now become ‘normal’ unemployment levels require new solutions, and tradewithout full employment exacerbates the problem

An interview with young migrants living in Mali’s capital city of Bamako

Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D

The New York Times has now pushed to the front page of today’s paper an issue of real relevance to INET: how new web tools are beginning to upend traditional peer review in academia.

Affordable medicines remain out of reach for millions because pharmaceutical innovation is organized around value extraction, not public health. How do shareholder-driven governance and fragmented global health financing reinforce inequity, and what structural reforms are needed to reverse it?

Low interest rate policy can only do so much to bring the relief to American borrowers that they deserve: past monetary policies, credit market regulations and stagnant labor productivity growth all get in the way. Interest rate policy activism is part of the problem, not the solution.